5Mak P,Leav I,Pursell B,et al. ERbeta impedes prostate cancer EMTby destabilizing HIF-1 alpha and inhibiting VEGF-mediated snail nu-clear localization: implications for Gleason grading. Cancer Cell,2010,17:319-332.
6Zhu K,Dai Z,Pan Q,et al. Metadherin promotes hepatocellular carci-noma metastasis through induction of epithelial-mesenchymal transi-tion. Clin Cancer Res,2011,17 :7294-7302.
7Ke AW,Shi GM,Zhou J,et al. CD151 amplifies signaling by integrinalpha6betal to PI3K and induces the epithelial-mesenchymal transi-tion in HCC cells. Gastroenterology, 2011,140:1629-1641.
8Mantovani A,Savino B,Locati M, et al. The chemokine system incancer biology and therapy. Cytokine Growth Factor Rev,2010,21 :27-39.
9Zheng K,Li HY,Su XL,et al. Chemokine receptor CXCR7 regulatesthe invasion, angiogenesis and tumor growth of human hepatocellularcarcinoma cells. J Exp Clin Cancer Res,2010,29:31.
10Xu J,Liu H,Chen L,et al. Hepatitis B virus X protein confers resist-ance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology ,2012,143 : 199-212.
6Zhuang PY, Zhang JB, Zhu XD,et al. Two pathologic types of hepato-cellular carcinoma with lymph node metastasis with distinct prognosison the basis of CK19 expression in tumor. Cancer,2008,112:2740-2748.
7Sun FX,Tang ZY,Lui KD,et al. Establishment of a metastatic modelof human hepatocelhilar carcinoma in nude mice via orthotopic im-plantation of histologically intact tissues. Int J Cancer, 1996 ,66 :239-243.
8Paterlini-Brechot P,Benali NL. Circulating tumor cells ( CTC) detec-tion :clinical impact and future directions. Cancer Lett, 2007 , 253 :180-204.
